UROKINASES SYNER MEDICA 500.000

UROKINASES SYNER MEDICA 500.000
Product Description

Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae - extensive acute proximal deep vein thrombosis - acute massive pulmonary embolism - acute occlusive peripheral arterial disease with limb threatening ischemia

Read more Show less

Mana Pharma

  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)
View company profile
Categories
more categories Show less

Mana Pharma

  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)
View company profile

More Products from Mana Pharma (7)

  • Edrophonium bromide

    Product Edrophonium bromide

    Cognitive & Mental Function; Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents, including synthetic ones, in prolonged apnoea and in any syndrome involving any syndrome involving atony of the striated or smooth fibre musculature striated or smooth fibre ...
  • Procainamide Hydrochloride

    Product Procainamide Hydrochloride

    Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies.
  • ANTICUDE

    Product ANTICUDE

    Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents and synthetic ones, in prolonged apnea and in any syndrome involving atony of the striated or smooth fibre musculature. It is also used in the diagnosis and treatment of myasthenia gravis and to aid in th...
  • BIOCORYL 100 MG/ML

    Product BIOCORYL 100 MG/ML

    Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies. 
  • Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia
  • Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemi...
  • Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia

Mana Pharma resources (2)